Kanagawa, Japan

Masahiro Hatsu

This inventor holds 2 USPTO granted patents. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Masahiro Hatsu

Introduction

Masahiro Hatsu is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel physiologically active substances. His work has led to advancements in understanding the inhibition of progesterone binding to its receptor.

Latest Patents

Hatsu holds 2 patents for his latest inventions, which include physiologically active substances PF1092A, PF1092B, and PF1092C. These substances were developed through the culturing of a fungal microorganism from the genus Penicillium. The process involved using a medium with ordinary nutrients for microorganisms and isolating the active substances through solvent extraction and silica gel column chromatography. The molecular formulae for these substances are C.sub.17 H.sub.20 O.sub.5, C.sub.17 H.sub.20 O.sub.5, and C.sub.15 H.sub.18 O.sub.4, respectively.

Career Highlights

Masahiro Hatsu is currently employed at Meiji Seika Kaisha, Ltd., where he continues to innovate and contribute to the field of biochemistry. His research focuses on the development of substances that can have significant physiological effects, particularly in relation to hormonal interactions.

Collaborations

Hatsu has worked alongside notable colleagues such as Yuji Tabata and Naoko Miike. Their collaborative efforts have furthered the research and development of innovative substances in the field.

Conclusion

Masahiro Hatsu's contributions to the field of biochemistry through his innovative patents highlight the importance of research in developing new physiologically active substances. His work continues to influence the scientific community and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…